Cardiff Lexington Corp Files 2023 Annual Report on Form 10-K
Ticker: CDIX · Form: 10-K · Filed: Mar 27, 2024 · CIK: 811222
Sentiment: neutral
Topics: 10-K, Annual Report, Cardiff Lexington Corp, Financials, Healthcare Services
TL;DR
<b>Cardiff Lexington Corporation has filed its annual 10-K report for the fiscal year ending December 31, 2023, detailing its financial performance and corporate structure.</b>
AI Summary
Cardiff Lexington Corp (CDIX) filed a Annual Report (10-K) with the SEC on March 27, 2024. Cardiff Lexington Corporation filed its 10-K report for the fiscal year ending December 31, 2023. The company's principal business address is located at 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169. Cardiff Lexington Corporation was formerly known as Cardiff International Inc., United American Inc., and Cardiff Financial Inc. The company's Standard Industrial Classification code is 8011, indicating Services - Offices & Clinics of Doctors of Medicine. The filing includes detailed financial data for the fiscal years 2023 and 2022, covering various stock and preferred stock series.
Why It Matters
For investors and stakeholders tracking Cardiff Lexington Corp, this filing contains several important signals. This filing provides a comprehensive overview of the company's financial health and operational status for the past fiscal year, crucial for investors and stakeholders to assess performance and future prospects. Understanding the company's historical name changes and its classification within the healthcare services sector offers context for its business evolution and market positioning.
Risk Assessment
Risk Level: low — Cardiff Lexington Corp shows low risk based on this filing. The filing is a standard annual report (10-K) and does not contain immediate red flags or significant negative developments, indicating a routine disclosure.
Analyst Insight
Review the detailed financial statements and risk factors within the 10-K to assess Cardiff Lexington Corp's financial health and strategic direction.
Key Numbers
- 2023-12-31 — Fiscal Year End (Report period)
- 2024-03-27 — Filing Date (Date the 10-K was filed)
- 8011 — SIC Code (Services-Offices & Clinics of Doctors of Medicine)
Key Players & Entities
- Cardiff Lexington Corp (company) — Filer of the 10-K report
- 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169 (location) — Business and mailing address
- 8011 (other) — Standard Industrial Classification code
- Cardiff International Inc. (company) — Former company name
- United American Inc. (company) — Former company name
- Cardiff Financial Inc. (company) — Former company name
FAQ
When did Cardiff Lexington Corp file this 10-K?
Cardiff Lexington Corp filed this Annual Report (10-K) with the SEC on March 27, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by Cardiff Lexington Corp (CDIX).
Where can I read the original 10-K filing from Cardiff Lexington Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Cardiff Lexington Corp.
What are the key takeaways from Cardiff Lexington Corp's 10-K?
Cardiff Lexington Corp filed this 10-K on March 27, 2024. Key takeaways: Cardiff Lexington Corporation filed its 10-K report for the fiscal year ending December 31, 2023.. The company's principal business address is located at 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169.. Cardiff Lexington Corporation was formerly known as Cardiff International Inc., United American Inc., and Cardiff Financial Inc..
Is Cardiff Lexington Corp a risky investment based on this filing?
Based on this 10-K, Cardiff Lexington Corp presents a relatively low-risk profile. The filing is a standard annual report (10-K) and does not contain immediate red flags or significant negative developments, indicating a routine disclosure.
What should investors do after reading Cardiff Lexington Corp's 10-K?
Review the detailed financial statements and risk factors within the 10-K to assess Cardiff Lexington Corp's financial health and strategic direction. The overall sentiment from this filing is neutral.
How does Cardiff Lexington Corp compare to its industry peers?
Cardiff Lexington Corporation operates within the healthcare services sector, specifically focusing on offices and clinics of doctors of medicine.
Are there regulatory concerns for Cardiff Lexington Corp?
As a publicly traded company, Cardiff Lexington Corporation is subject to SEC regulations, including the requirement to file annual reports (10-K) detailing its financial condition and operations.
Industry Context
Cardiff Lexington Corporation operates within the healthcare services sector, specifically focusing on offices and clinics of doctors of medicine.
Regulatory Implications
As a publicly traded company, Cardiff Lexington Corporation is subject to SEC regulations, including the requirement to file annual reports (10-K) detailing its financial condition and operations.
What Investors Should Do
- Analyze the financial statements within the 10-K for revenue, net income, and other key performance indicators for fiscal years 2023 and 2022.
- Review any disclosed risk factors to understand potential challenges and uncertainties facing the company.
- Examine the company's business description and historical information to grasp its operational focus and evolution.
Key Dates
- 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K.
- 2024-03-27: Filing Date — Date the 10-K was officially submitted to the SEC.
Glossary
- 10-K
- An annual report required by the U.S. Securities and Exchange Commission (SEC), which gives a comprehensive summary of a company's financial performance. (This filing provides the official annual financial overview of Cardiff Lexington Corp.)
- SIC Code
- Standard Industrial Classification code used to classify businesses based on their primary activity. (Indicates Cardiff Lexington Corp operates within the healthcare services sector (Doctors of Medicine).)
Year-Over-Year Comparison
This is the initial filing analyzed, so no comparison to a previous filing is available.
Filing Stats: 4,500 words · 18 min read · ~15 pages · Grade level 16.2 · Accepted 2024-03-27 14:04:42
Key Financial Figures
- $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value Indicate by check mark if th
Filing Documents
- cardiff_i10k-123123.htm (10-K) — 1813KB
- cardiff_ex0304.htm (EX-3.4) — 13KB
- cardiff_ex0306.htm (EX-3.6) — 4KB
- cardiff_ex0308.htm (EX-3.8) — 12KB
- cardiff_ex0310.htm (EX-3.10) — 13KB
- cardiff_ex0312.htm (EX-3.12) — 13KB
- cardiff_ex0314.htm (EX-3.14) — 13KB
- cardiff_ex0316.htm (EX-3.16) — 13KB
- cardiff_ex0318.htm (EX-3.18) — 178KB
- cardiff_ex0401.htm (EX-4.1) — 123KB
- cardiff_ex1019.htm (EX-10.19) — 72KB
- cardiff_ex1020.htm (EX-10.20) — 70KB
- cardiff_ex1022.htm (EX-10.22) — 73KB
- cardiff_ex1023.htm (EX-10.23) — 42KB
- cardiff_ex1024.htm (EX-10.24) — 42KB
- cardiff_ex1901.htm (EX-19.1) — 85KB
- cardiff_10k-ex2101.htm (EX-21.1) — 3KB
- cardiff_ex2301.htm (EX-23.1) — 2KB
- cardiff_10k-ex3101.htm (EX-31.1) — 11KB
- cardiff_10k-ex3102.htm (EX-31.2) — 11KB
- cardiff_10k-ex3201.htm (EX-32.1) — 4KB
- cardiff_10k-ex3202.htm (EX-32.2) — 4KB
- image_002.jpg (GRAPHIC) — 75KB
- image_017.jpg (GRAPHIC) — 256KB
- image_021.jpg (GRAPHIC) — 852KB
- image_022.jpg (GRAPHIC) — 810KB
- image_023.jpg (GRAPHIC) — 412KB
- image_026.jpg (GRAPHIC) — 635KB
- image_027.jpg (GRAPHIC) — 397KB
- image_032.jpg (GRAPHIC) — 638KB
- image_033.jpg (GRAPHIC) — 896KB
- image_034.jpg (GRAPHIC) — 852KB
- image_035.jpg (GRAPHIC) — 397KB
- image_036.jpg (GRAPHIC) — 255KB
- image_040.jpg (GRAPHIC) — 851KB
- image_041.jpg (GRAPHIC) — 811KB
- image_042.jpg (GRAPHIC) — 399KB
- image_047.jpg (GRAPHIC) — 601KB
- image_048.jpg (GRAPHIC) — 864KB
- image_049.jpg (GRAPHIC) — 830KB
- image_050.jpg (GRAPHIC) — 371KB
- image_055.jpg (GRAPHIC) — 631KB
- image_056.jpg (GRAPHIC) — 913KB
- image_057.jpg (GRAPHIC) — 873KB
- image_058.jpg (GRAPHIC) — 373KB
- image_063.jpg (GRAPHIC) — 599KB
- image_064.jpg (GRAPHIC) — 847KB
- image_065.jpg (GRAPHIC) — 854KB
- image_066.jpg (GRAPHIC) — 413KB
- ex318cover.jpg (GRAPHIC) — 179KB
- 0001683168-24-001750.txt ( ) — 32489KB
- cdif-20231231.xsd (EX-101.SCH) — 63KB
- cdif-20231231_cal.xml (EX-101.CAL) — 69KB
- cdif-20231231_def.xml (EX-101.DEF) — 228KB
- cdif-20231231_lab.xml (EX-101.LAB) — 423KB
- cdif-20231231_pre.xml (EX-101.PRE) — 350KB
- cardiff_i10k-123123_htm.xml (XML) — 1429KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations. 35 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk. 45 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data. 45 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 45 Item 9A.
Controls and Procedures
Controls and Procedures. 45 Item 9B. Other Information. 47 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 47 PART III Item 10. Directors, Executive Officers and Corporate Governance. 48 Item 11.
Executive Compensation
Executive Compensation. 51 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 56 Item 13. Certain Relationships and Related Transactions, and Director Independence. 5 7 Item 14. Principal Accounting Fees and Services. 57 PART IV Item 15. Exhibit and Financial Statement Schedules. 58 Item 16. Form 10-K Summary. 60 i INTRODUCTORY NOTES Use of Terms Except as otherwise indicated by the context and for the purposes of this report only, references in this report to "we," "us," "our" and "our company" are to Cardiff Lexington Corporation, a Nevada corporation, and its consolidated subsidiaries. Special Note Regarding Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management's beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our ability to successfully identify and acquire additional businesses; our ability to effectively integrate and operate the businesses that we acquire; our expectations around the performance of our current businesses; our ability to maintain our business model and improve our capital efficiency; our ability to effectively manage the growth of our business; our ability to maintain profitabi